Clients Affected: All importers and brokers
This notice is to advise trade chain partners (TCPs) (i.e. importers and brokers) that are using the Single Window Initiative (SWI), Integrated Import Declaration (IID) to obtain release for human drugs that will be used in clinical trials that Health Canada is validating the entry against the last 6 digits of the Dossier # rather than the 6 digit control number. This number is included in the Clinical Trial No Objection Letter (document type 5013) in the top right corner of the letter.
For example, if the Clinical Trial No Objection Letter indicates the Dossier ID: HC-024-C123456, then the digits, 123456, are to be entered for document type 5013.